MedPath

Markavyuktakshir Nasya for vyanga(melasma) patients for 15 days

Phase 2
Conditions
Health Condition 1: L578- Other skin changes due to chronicexposure to nonionizing radiationHealth Condition 2: L55-L59- Radiation-related disorders of the skin and subcutaneous tissue
Registration Number
CTRI/2023/11/060205
Lead Sponsor
PDEAS college of ayurved and research centre Nigadi pune
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients showing classical signs and symptoms of vyanga like tanu, niruja, shyava mandal on face.

2.Patients of age between 25 to 55 years irrespective of gender, religion and economic status

Exclusion Criteria

1.Vyanga caused due to any known systemic disease like Addison’s disease, Cushing’s syndrome.

2.Vyanga caused since birth like Nevus of Ota

3.Vyanga along with kushta roga

4.Hyper pigmentation caused by known case of tumour like malignant melanoma

5.Pregnant and lactating women

6.Patient’s anarha for nasya karma

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Evaluate efficacy of markavyuktakshir nasya in management of vyanga for 15 daysTimepoint: 3 follow ups will be taken on 7th,15th and 21th day and the treatment will be given for 15 days
Secondary Outcome Measures
NameTimeMethod
To observe the adverse effect if any for 15 daysTimepoint: 15 days study with 3 folow ups 7th, 15th and 21th day
© Copyright 2025. All Rights Reserved by MedPath